Biotech Business Week articles from December 2003

Biotech Business Week archives from December 2003

National coverage initiated for DNAwithPap test.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Digene Corporation (DIGE) announced that Cigna Healthcare has updated their cervical cancer screening Clinical Resource Tool to include human papillomavirus (HPV) testing in combination with a Pap test...

GenSci announces name change, delisting from TSX and listing on NEX.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- SMC Ventures, Inc., (SMV.H), previously GenSci Regeneration Sciences, Inc., (GNS) announced that, as a result of the completion of its plan of arrangement, and the acquisition of substantially all of...

Flavin Ventures announces funding of proteomic service provider.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Flavin Ventures has announced the start up and funding of its first new biotechnology venture since its recent establishment. Flavin Ventures has helped launch Shamrock Structures, a Chicago,...

Study: Newborn screening cost-effective in detecting MCADD.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Screening newborns for a rare but treatable genetic disease benefits families and society, according to a team of pediatricians and healthcare economists who analyzed patient records and data from mass...

Merger of drug delivery, biotech firms valued at $515M.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Cephalon, Inc., (CEPH) and Cima Labs, Inc., (Cima) announced that they have signed a definitive merger agreement under which Cephalon will acquire all the outstanding common shares of Cima for $34 per...

Company works to amend its non-approvable New Drug Application.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Noven Pharmaceuticals, Inc., (NOVN) provided an update on the status of MethyPatch, its developmental methylphenidate transdermal system for attention deficit hyperactivity disorder. MethyPatch is...

Domestic animals may be bioterrorism targets; broad health, economic damage possible.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Domestic animals may be bioterrorism targets; broad health, economic damage possible. According to a study from France, "after a brief historical introduction, the authors describe a list of...

FDA approval granted for loratadine.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Andrx Corporation (ADRX) announced that the U.S. Food and Drug Administration (FDA) has approved the marketing of its Abbreviated New Drug Application (ANDA) for its loratadine orally disintegrating...

Data reported on monthly injectable sustained-release formulation of ZT-1.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- At the 4th Neurobiology of Aging Conference in New Orleans, Louisiana, Debiopharm S.A. (Debiopharm) presented the results of an in vivo evaluation in rats of an injectable once-monthly sustained-release...

Three disease compounds acquired from Sankyo.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- BTG (BGC) has acquired the intellectual property rights to a portfolio of preclinical compounds designed to treat Alzheimer disease, from Sankyo Co., Ltd., Japan. The portfolio encompasses three...

Infusions of synthetic HDL may remove plaque from coronary arteries.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- A new study appearing in the November 5 edition of the Journal of the American Medical Association provides strong evidence that five weekly infusions of a synthetic form of "good cholesterol," or HDL,...

Phase II data from study of ETC-216 show plaque accumulation can be reversed.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Esperion Therapeutics, Inc., (ESPR) announced the results of a study providing significant evidence that its investigational product candidate, ETC-216 (ApoA-I Milano/phospholipid complex or AIM),...

Stimulation of reverse cholesterol transport can result in regression of plaque.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Lipid Sciences, Inc., (LIPD), announced that an article published on November 5, 2003, in the Journal of the American Medical Association (JAMA), supports the premise on which its Vascular Lipid Removal...

Uroxatral launched in U.S. to treat symptoms of benign prostatic hyperplasia.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Sanofi-Synthelabo announced that Uroxatral (alfuzosin hydrochloride extended-release tablets) has been launched in the U.S. as a 10 mg, once-daily prescription alpha1-blocker that provides effective...

Benign prostatic hypertrophy drug available in U.S.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- SkyePharma PLC (SKYE) announced that Sanofi-Synthelabo (SNY) has launched Uroxatral (alfuzosin hydrochloride) in the U.S. market for the relief of urinary symptoms associated with benign prostatic...

Genome-wide human genetic variation map complete.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Applied Biosystems Group (ABI), an Applera Corporation business, announced that it has completed the development of a genome-wide human genetic variation map based on single nucleotide polymorphisms...

Perfluorocarbon-based blood substitute undergoes phase I clinical trial.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Synthetic Blood International Inc. (SYBD) announced that a phase I clinical trial of Oxycyte, its perfluorocarbon-based blood substitute, started on October 30, 2003, and believes that Oxycyte may be...

BSE test detects youngest case of Mad Cow disease in Japan.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Bio-Rad Laboratories, Inc., (BIO, BIO.B), a multinational manufacturer and distributor of life science research products and clinical diagnostics announced that its bovine spongiform encephalopathy...

FDA gives approval for phase III registrational trial for breast cancer drug.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- YM BioSciences Inc. (YMBA) has received written confirmation from the U.S. Food and Drug Administration (FDA) that it may initiate a pivotal phase III, or registrational trial, for its lead...

Canadian study confirms women with implants require more medical care.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- A new study by epidemiologists at the British Columbia Centre of Excellence for Women's Health, finds that Canadian women with breast implants use much more medical services than other women of the same...

Radiofrequency ablation being used to treat cancerous tumors.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Radiofrequency ablation (RFA) is a minimally invasive procedure that is being used to treat certain cancers at The American Institute for Cancer Ablation. A needle is inserted into the tumor using...

Cardiac patient with complications delivers healthy baby.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- At the age of 25, Nancy DePrete was told that she had a 10% chance of having a baby. After suffering a stroke at the age of 24 and being diagnosed with non-Hodgkin lymphoma at the age of 25, Nancy's...

World's first integrated system to increase safety of cell therapy.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Thermogenesis Corp. (KOOL) and Mediware Information Systems, Inc., (MEDW) said they will jointly develop and market the industry's first fully integrated system to make personalized cell therapy safer...

Niaspan launched in the United Kingdom.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Kos Pharmaceuticals, Inc., (KOSP) announced that Merck Pharmaceuticals, UK, a subsidiary of Merck, KGaA, Germany, has launched Niaspan (extended-release niacin) in the United Kingdom (U.K.), a...

FDA urged to base animal cloning policy on long-term research.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- In response to the U.S. Food and Drug Administration's (FDA) preliminary announcement that products from cloned animals are safe to eat, the Organic Trade Association, which represents the $11 billion...

Alliance targets siRNA research using GeneChip technology.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Qiagen N.V. (QGENF, QIA) and Affymetrix, Inc., (AFFX) announced that they have entered into a collaboration to optimize Qiagen siRNA-mediated gene silencing using Affymetrix GeneChip microarray...

Alliance with the Cleveland Clinic uses imaging system in cancer research.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Applied Imaging Corp. announced the formation of a clinical research imaging collaboration with the Department of Anatomic Pathology at The Cleveland Clinic Foundation. As part of this...

AlphaNet to provide services to emphysema patients who rely on Zemaira.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Aventis Behring, LLC, announced an agreement with AlphaNet, Inc., a not-for-profit health management company, to provide health management and support services to patients who rely on Zemaira...

Company gets $20M from Bristol-Myers Squibb as part of Basulin project.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Flamel Technologies (FLML) announced the receipt of the $20 million upfront payment from Bristol-Myers Squibb in respect of its Basulin project. Flamel's cash and cash equivalents are approximately...

Haemonetics announces intent to sign distribution agreement with French firm.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Haemonetics Corp. (HAE) and Hemosystem, S.A., announced that the companies have signed an agreement confirming each party's intent to enter an agreement for Haemonetics' exclusive marketing and...

IDI inks agreements regarding its real-time diagnostic products.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Infectio Diagnostic, Inc., (IDI) and Cepheid have concluded new agreements and have decided to terminate current ARIDIA joint venture. These new agreements will enable IDI and Cepheid to increase...

Joint development agreement signed for MRI devices.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Biophan Technologies, Inc., (BIPH) announced that it had entered into a joint development agreement with Boston Scientific Corporation (BSX) to make medical devices more compatible with magnetic...

Marketing agreement signed for Collagenase Santyl Ointment.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- BioSpecifics Technologies Corp. (BSTC) announced that the Ross Products Division of Abbott Laboratories, Inc., will assume United States marketing responsibility for Collagenase Santyl Ointment...

Medarex announces achievement of milestone in agreement.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Medarex, Inc., (MEDX) has achieved a significant milestone under its 1999 agreement with Amgen, Inc. The achievement of this milestone will trigger an undisclosed payment to Medarex. "We are...

Miikana Therapeutics inks strategic alliance for antibody development.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Miikana Therapeutics, Inc., and NovImmune, SA, have established a collaboration to develop fully human antibody-based therapeutics for the treatment of cancer and immune diseases. The resulting...

Partnership with Infectio Diagnostics restructured.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Cepheid (CPHD) announced that Cepheid and Infectio Diagnostics, Inc., (IDI) of Quebec, Canada, have executed a series of new agreements resulting in a restructuring of their previously existing...

Preliminary agreement for Sucanon sales in Mexico concluded.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Robert Rieveley, the president of Biotech Holdings (BIO.V, BIOHF.OB), announced that the company has concluded a preliminary agreement with a marketing company who will bring the company's Sucanon...

Research agreement signed for testing of topical anti-herpes formulations.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- CytoGenix, Inc., (CYGX) has signed an agreement with the DermPharm division of DermTech International, Inc., a firm specializing in dermatology safety and efficacy testing with experience in the U.S....

Research alliance to combine reverse transfection and siRNA.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Dharmacon, Inc., a supplier of RNA and RNA interference (RNAi) research products, and Akceli, Inc., a cellular systems biology company, announced a research collaboration to study the utility of...

Low infection rate seen in Arrow Lionheart European trial.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- The results of the first study of the Arrow LionHeart, a heart assist device conceived of and developed at Penn State College of Medicine in cooperation with Arrow International, Inc., show low...

Protein engineering firm moves facilities.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- BioTech Studio LLC, a new company offering to engineer proteins for the pharmaceutical industry, has moved into the region's premier life science and technology business incubator, the Science Center...

Patient enrollment initiated in study of vascular sealant product.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Closure Medical Corporation (CLSR) announced the first use in humans of its synthetic vascular sealant product under the company's U.S. Food and Drug Administration (FDA)-approved clinical trial. ...

Drug use climbed in the U.S. workforce in the first half of 2003.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Drug use in the general U.S. workforce climbed in the first half of 2003, driven by continued growth in the use of amphetamines, according to the semi-annual Drug Testing Index released by Quest...

Positive study results released on GPCR targeted library.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- The Genomics Institute of the Novartis Research Foundation (GNF) and ChemBridge Research Laboratories, LLC, (CRL) announced results on GNF's evaluation of CRL's GPCR Targeted Library. Key...

Company reaches milestones in two research alliances with Baxter Healthcare.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Jerini, AG, has successfully passed first milestones in two research alliances entered into with Baxter in 2001 and 2002. Jerini has optimized peptide lead molecules identified against two...

Lilly purchases integrated cellular screening system.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Amersham (AHM) announced that Eli Lilly and Co. (LLY) has purchased an integrated suite of cellular screening technology and licenses to help in the identification of potential therapeutics in its drug...

Research agreement supports computer-assisted molecular design of medicines.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Shionogi & Co., Ltd., has entered into a joint research agreement with Professor Shin-ichiro Nishimura of the Hokkaido University Faculty of Science to use carbohydrate-related functional bioinformatic...

New systems could find chemical residues, mad cow disease and SARS.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- The University at Buffalo (UB) has established the Center for Unified Biometrics and Sensors, (CUBS) a new cross-disciplinary center that takes a unique approach to developing technologies in...

Primary endpoints met in phase IIb study of erectile dysfunction drug.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Palatin Technologies, Inc., (PTN) announced the presentation of positive safety and efficacy data from its phase IIb "at home" study of PT-141 for male sexual dysfunction. Men with erectile...

Assay maker reports loss of $0.14 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Aclara BioSciences (ACLA) reported financial results for the 3 months ended September 30, 2003. Revenue for the 3 months ended September 30, 2003, was $276,000, compared to revenue for the 3 months...

Biopharma company announces third quarter 2003 financial results.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- GenVec, Inc., (GNVC), a biopharmaceutical company, announced financial results for the third quarter ended September 30, 2003. GenVec reported higher revenues and a lower net loss through the first...

Biotech company reports 6% increase in sales.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- BioSource International, Inc., (BIOI) announced its operating results for the third quarter and 9 months ended September 30, 2003. Net sales for the 3 months ended September 30, 2003, were $10.7...

Biotech company reports loss of $0.21 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Array BioPharma, Inc., (ARRY) reported financial results for the first quarter of fiscal 2004, ended September 30, 2003. During the first quarter of fiscal 2004, Array reported total revenue of...

Biotech firm raises $22M in private equity transaction.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- EntreMed, Inc., (ENMD) has raised approximately $22.3 million in gross proceeds in an issuance of common stock and warrants to certain independent institutional investors. Proceeds from the...

Cell therapy company launches direct stock purchase program.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) announced that registered shareholders of the company can purchase up to an aggregate of 10 million newly issued shares of its stock through Aastrom's Direct Stock...

Chemistry drug company reports 41.6% increase n revenue.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Albany Molecular Research, Inc., (AMRI) reported financial results for the quarter and 9-month period ending September 30, 2003. Total revenue for the third quarter of 2003 increased by $13.3...

Device company's executives enter into Rule 10b5-1 trading programs.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Alaris Medical Systems, Inc., (AMI) announced that several executives, including David L. Schlotterbeck, president and chief executive officer, have adopted pre-arranged trading plans permitted under...

Drug delivery company reports loss of $0.31 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Alkermes, Inc., (ALKS) reported its financial results for the 3-month period ended September 30, 2003. The net loss on a GAAP basis for the quarter ended September 30, 2003, was $26.2 million or...

Electrosurgical products company's stock listed on Amex.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- The American Stock Exchange (Amex) listed the common stock of Bovie Medical Corporation under the ticker symbol BVX. Bovie Medical Corporation is actively engaged in the business of manufacturing...

Enzyme Therapy maker reports quarterly loss of $0.33 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- BioMarin Pharmaceutical, Inc., (BMRN) announced financial results for its third quarter ended September 30, 2003. The net loss was $21.3 million ($0.33 per share) for the third quarter of 2003...

Follow-on offering reported by pharmaceutical firm; guidance issued.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Bradley Pharmaceuticals, Inc., (BDY) announced that it has filed a Registration Statement on Form S-3 with the U.S. Securities and Exchange Commission relating to a proposed follow-on offering of...

Generic drug maker reports 38.9% increase in sales.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Able Laboratories, Inc., (ABRX, AAB) announced financial results for the 3 months ended September 30, 2003. For the third quarter of 2003, the company reported net sales of $20.9 million, a 38.9%...

Genomics company reports loss of $0.01 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Epoch Biosciences, Inc., (EBIO) reported revenues for the third quarter of $2.0 million compared to $2.7 million in the like period in 2002, which included $686,000 of revenue from the San Diego,...

Genomics company reports loss of $0.35 per share; provides pipeline update.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Exelixis, Inc., (EXEL) reported financial results for the quarter ended September 30, 2003. For the quarter ended September 30, 2003, the company reported a net loss of approximately $25.0 million,...

Hemodialysis company reports per share loss of $0.19.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Aksys, Ltd., (AKSY) reported results for the quarter ended September 30, 2003. For the third quarter of 2003, Aksys reported total revenues of $411,000 compared to $169,000 for the third quarter of...

Immunotherapeutics company reports $7.4M in revenue.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Corixa Corp. (CRXA) announced financial results for the third quarter ended September 30, 2003. The company also announced it is restructuring its operations to focus on priority programs and...

Inflammatory diseases drug maker files resale registration statement with SEC.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- AtheroGenics, Inc., (AGIX) announced that it has filed a resale registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC) pertaining to its Convertible Notes issued on...

Insulin system maker reports loss of $0.08 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Aradigm Corporation (ARDM) announced financial results for the third quarter and 9 months ended September 30, 2003. Contract revenues for the quarter were $9.8 million, compared to $6.0 million for...

Medical device company closes on $23.5 million of series D financing.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Percardia, Inc., recently completed a second close on its Series D financing, raising $23.5 million total in the Series D financing round. Investors in this round include, Percardia LLC, Prism...

Medical device firm reports 9% increase in revenue.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Becton, Dickinson and Company (BD) (BDX) reported record quarterly revenues of $1.177 billion for the fiscal fourth quarter ended September 30, 2003, an increase of 9% from the same period a year ago....

Medical device maker announces move to Amex.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Bovie Medical Corporation (BVX), a manufacturer and marketer of electrosurgery products, listed its common stock on the American Stocks Exchange (Amex) under the ticker symbol BVX. "We are excited...

Metabolic disease drug maker reports loss of $0.40 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Amylin Pharmaceuticals, Inc., (AMLN) reported financial results for the third quarter ended September 30, 2003. The company reported a net loss of $37.5 million, or $0.40 per share, and $105.5...

Microfluidics company reports loss of $0.37 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Caliper Technologies Corp. (CALP) announced its third quarter 2003 financial results. These results include the financial results of Zymark Corporation from July 14, 2003, (the acquisition date)...

Neugene maker reports net loss of $0.15 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- AVI BioPharma, Inc., (AVII) reported financial results for the 3 and 9 months ended September 30, 2003, and provided an update on its clinical pipeline. For the third quarter of 2003, the company...

Neurological disease biotech company reports loss of $0.07 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Axonyx, Inc., (AXYX) announced its results for the third quarter ended September 30, 2003. The company reported a net loss to shareholders of $1,803,000 or $0.07 per share for the third quarter of...

Offering of 35M shares closed by pharmaceutical firm.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Elan Corporation, plc, (ELN) announced that it has completed the offering and sale of 35 million ordinary shares at a price of $4.95 per share. Elan also announced that it expected to complete the...

Oncology company reports loss of $0.19 per share.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) reported financial results for the third quarter of 2003. For the 3 months ended September 30, 2003, the company reported a net loss of $5.0 million, or $0.19 per...

Oncology drug maker reports $0.08 per share loss.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Cytogen Corporation (CYTO) reported its consolidated financial results for the 3- and 9-month periods ended September 30, 2003. Total revenues were $5.51 million for the third quarter of 2003...

Pain management drug maker announces pricing of common stock.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Adolor Corporation (ADLR) announced the pricing of a public offering of 6,000,000 shares of its common stock at $17.25 per share. The gross proceeds from the offering are expected to be $103.5...

Pain medication maker reports royalty income increased 23%.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- A.P. Pharma, Inc., (APPA) reported financial results for the 3 months ended September 30, 2003, reflecting increased royalty income and contract revenues. A.P. Pharma reported that total revenues...

Pharmaceutical company announces third quarter 2003 financial results.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Rigel Pharmaceuticals, Inc., (RIGL) reported financial results for the third quarter and 9 months that ended September 30, 2003. Rigel reported revenue from collaborations of $2.1 million in the...

Pharmaceutical company boosts sales by 13% worldwide.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Altana AG (AAA; ALT) reported sales of around EUR 2 billion for the first 9 months of 2003, up 5% on the equivalent previous year's figure. "Despite the worldwide economic slump, the weak dollar,...

Pharmaceutical company reports 63% increase in net income in third quarter.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Teva Pharmaceutical Industries Ltd. (TEVA) reported net income of $157 million for the third quarter of 2003, up 63%. Fully diluted EPS reached $0.53, up 47%, and net sales for the quarter...

Pharmaceutical company reports net loss in third quarter 2003.
December 1, 2003... 2003 DEC 1 - (NewsRx.com & NewsRx.net) -- Sonus Pharmaceuticals, Inc., (SNUS) reported financial results for the third quarter ended September 30, 2003. For the third quarter of 2003, Sonus reported a net loss of $2.5 million, or $0.15 per...